Furthermore, ANGPTL4 inhibition via antisense oligonucleotides or c-ANGPTL4 antibodies lead to dose-dependent attenuation of EMT markers in a 3D-tumor model [59]. The gene discussed is ANGPTL4; the disease is neoplasm.